Patents by Inventor Eugene Jans

Eugene Jans has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combination Therapy Regimen For Treatment Of Selected HCV Genotypes
    Publication number: 20180021360
    Abstract: A method for the treatment of hepatitis C infection genotype 1, 2, 4, 5, or 6, but not genotype 3 is provided comprising administering an effective amount of a combination of Compound (I), Compound (II), and Compound (III), or independently optionally their pharmaceutically acceptable salt, solvate or hydrate, optionally in a solid fixed dose composition.
    Type: Application
    Filed: July 21, 2017
    Publication date: January 25, 2018
    Applicants: Janssen Pharmaceuticals, Inc., Achillion Pharmaceuticals, Inc.
    Inventors: Maria Gloria Beumont, Lieve Bijnens, Lawrence M. Blatt, Sushmita Mukherjee Chanda, John Fry, Eugene Jans, Thomas Naoki Kakuda, Sivi Mahadevan, Roel Mertens, Gaston Rafael Picchio, Alex Van Dijck, Peter Van Remoortere, David Apelian, Dawei Chen, Milind Deshphande, James Hui, Avinash Phadke
  • COMBINATION DRUG TREATMENT FOR HEPATITIS C INFECTION
    Publication number: 20180021361
    Abstract: A method for the treatment of hepatitis C infection genotype 1, 2, 4, 5, or 6 is provided comprising administering an effective amount of a combination of Compound (I), Compound (II), and Compound (III), or independently optionally their pharmaceutically acceptable salt, solvate or hydrate, optionally in a solid fixed dose composition.
    Type: Application
    Filed: July 21, 2017
    Publication date: January 25, 2018
    Applicants: JANSSEN PHARMACEUTICALS, INC., ACHILLION PHARMACEUTICALS, INC.
    Inventors: Maria Gloria Beumont, Lieve Bijnens, Lawrence M. Blatt, Sushmita Mukherjee Chanda, John Fry, Eugene Jans, Thomas Naoki Kakuda, Sivi Mahadevan, Roel Mertens, Gaston Rafael Picchio, Alex Van Dijck, Peter Van Remoortere, David Apelian, Dawei Chen, Milind Deshphande, James Hui, Avinash Phadke
  • COMBINATION DRUG TREATMENT FOR HEPATITIS C INFECTION
    Publication number: 20170319572
    Abstract: A composition, including a fixed dose composition, comprising Compound (I), Compound (II), and Compound (III) for the treatment of hepatitis C, and methods of manufacture thereof.
    Type: Application
    Filed: July 25, 2017
    Publication date: November 9, 2017
    Applicants: JANSSEN PHARMACEUTICALS, INC., ACHILLION PHARMACEUTICALS, INC.
    Inventors: Maria Gloria Beumont, Lieve Bijnens, Lawrence M. Blatt, Sushmita Mukherjee Chanda, John Fry, Eugene Jans, Thomas Naoki Kakuda, Sivi Mahadevan, Roel Mertens, Gaston Rafael Picchio, Alex Van Dijck, Peter Van Remoortere, David Apelian, Dawei Chen, Milind Deshphande, James Hui, Avinash Phadke
  • COMBINATION THERAPY REGIMEN FOR TREATMENT OF HCV
    Publication number: 20170087174
    Abstract: A composition, including a fixed dose composition, comprising Compound (I), Compound (II), and Compound (III) for the treatment of hepatitis C, and methods of manufacture thereof.
    Type: Application
    Filed: September 29, 2016
    Publication date: March 30, 2017
    Inventors: Maria Gloria Beumont, Lieve Bijnens, Lawrence M. Blatt, Sushmita Mukherjee Chanda, John Fry, Eugene Jans, Thomas Naoki Kakuda, Sivi Mahadevan, Roel Mertens, Gaston Rafael Picchio, Alex Van Dijck, Peter Van Remoortere, David Apelian, Dawei Chen, Milind Deshphande, James Hui, Avinash Phadke
  • Use of protein H as cytostatic agent
    Patent number: 6833355
    Abstract: The use of protein H, and fragments or derivatives thereof, as cytostatic agents, especially in the treatment of diseases involving undesired cell proliferation.
    Type: Grant
    Filed: May 11, 2000
    Date of Patent: December 21, 2004
    Assignee: Hansa Medical AB
    Inventors: Lars H. Björck, Inga-Maria Frick, Tomas Borje Leandersson, Eugen Jan Karol Axcrona